FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313590933> ?p ?o ?g. }

• W4313590933 endingPage "77" @default.
• W4313590933 startingPage "77" @default.
• W4313590933 abstract "Colorectal cancer (CRC), breast cancer, and chronic myeloid leukemia (CML) are life-threatening malignancies worldwide. Although potent therapeutic and screening strategies have been developed so far, these cancer types are still major public health problems. Therefore, the exploration of more potent and selective new agents is urgently required for the treatment of these cancers. Quinones represent one of the most important structures in anticancer drug discovery. We have previously identified a series of quinone-based compounds (ABQ-1-17) as anti-CML agents. In the current work, ABQ-3 was taken to the National Cancer Institute (NCI) for screening to determine its in vitro antiproliferative effects against a large panel of human tumor cell lines at five doses. ABQ-3 revealed significant growth inhibition against HCT-116 CRC and MCF-7 breast cancer cells with 2.00 µM and 2.35 µM GI50 values, respectively. The MTT test also showed that ABQ-3 possessed anticancer effects towards HCT-116 and MCF-7 cells with IC50 values of 5.22 ± 2.41 μM and 7.46 ± 2.76 μM, respectively. Further experiments indicated that ABQ-3 induced apoptosis in both cell lines, and molecular docking studies explicitly suggested that ABQ-3 exhibited DNA binding in a similar fashion to previously reported compounds. Based on in silico pharmacokinetic prediction, ABQ-3 might display drug-like features enabling this compound to become a lead molecule for future studies." @default.
• W4313590933 created "2023-01-06" @default.
• W4313590933 creator A5014836794 @default.
• W4313590933 creator A5023372956 @default.
• W4313590933 creator A5036554864 @default.
• W4313590933 creator A5040352588 @default.
• W4313590933 creator A5046040400 @default.
• W4313590933 creator A5050883078 @default.
• W4313590933 creator A5056440560 @default.
• W4313590933 creator A5067147087 @default.
• W4313590933 creator A5077836610 @default.
• W4313590933 creator A5083928087 @default.
• W4313590933 date "2022-12-22" @default.
• W4313590933 modified "2023-10-06" @default.
• W4313590933 title "Studies on 1,4-Quinone Derivatives Exhibiting Anti-Leukemic Activity along with Anti-Colorectal and Anti-Breast Cancer Effects" @default.
• W4313590933 cites W1260832570 @default.
• W4313590933 cites W128094615 @default.
• W4313590933 cites W1965912776 @default.
• W4313590933 cites W1977791869 @default.
• W4313590933 cites W1985162831 @default.
• W4313590933 cites W1998660934 @default.
• W4313590933 cites W2008757142 @default.
• W4313590933 cites W2017464987 @default.
• W4313590933 cites W2026846284 @default.
• W4313590933 cites W2033003773 @default.
• W4313590933 cites W2043518912 @default.
• W4313590933 cites W2056204720 @default.
• W4313590933 cites W2071935378 @default.
• W4313590933 cites W2072860434 @default.
• W4313590933 cites W2074452470 @default.
• W4313590933 cites W2079762751 @default.
• W4313590933 cites W2080116307 @default.
• W4313590933 cites W2080392472 @default.
• W4313590933 cites W2080891051 @default.
• W4313590933 cites W2092931894 @default.
• W4313590933 cites W2108300681 @default.
• W4313590933 cites W2109689528 @default.
• W4313590933 cites W2111136847 @default.
• W4313590933 cites W2118909720 @default.
• W4313590933 cites W2126275835 @default.
• W4313590933 cites W2143916432 @default.
• W4313590933 cites W2155208683 @default.
• W4313590933 cites W2158025958 @default.
• W4313590933 cites W2165148696 @default.
• W4313590933 cites W2170824196 @default.
• W4313590933 cites W2216172761 @default.
• W4313590933 cites W2303897250 @default.
• W4313590933 cites W2414038664 @default.
• W4313590933 cites W2414705916 @default.
• W4313590933 cites W2488531109 @default.
• W4313590933 cites W2519604159 @default.
• W4313590933 cites W2520903395 @default.
• W4313590933 cites W2567591159 @default.
• W4313590933 cites W2576899770 @default.
• W4313590933 cites W2593436234 @default.
• W4313590933 cites W2782775245 @default.
• W4313590933 cites W2792768542 @default.
• W4313590933 cites W2858827579 @default.
• W4313590933 cites W2936034288 @default.
• W4313590933 cites W2944171090 @default.
• W4313590933 cites W2947351976 @default.
• W4313590933 cites W2971360858 @default.
• W4313590933 cites W2979597925 @default.
• W4313590933 cites W2989718561 @default.
• W4313590933 cites W2990286446 @default.
• W4313590933 cites W3006381662 @default.
• W4313590933 cites W3006514606 @default.
• W4313590933 cites W3011481749 @default.
• W4313590933 cites W3012638502 @default.
• W4313590933 cites W3023752815 @default.
• W4313590933 cites W3037526368 @default.
• W4313590933 cites W3045101815 @default.
• W4313590933 cites W3075675148 @default.
• W4313590933 cites W3138395871 @default.
• W4313590933 cites W3168432527 @default.
• W4313590933 cites W3178305855 @default.
• W4313590933 cites W3199965461 @default.
• W4313590933 cites W3205266009 @default.
• W4313590933 cites W3206597818 @default.
• W4313590933 cites W3217745764 @default.
• W4313590933 cites W4205724345 @default.
• W4313590933 cites W4207077393 @default.
• W4313590933 cites W4213070443 @default.
• W4313590933 cites W4220684016 @default.
• W4313590933 cites W4291667730 @default.
• W4313590933 cites W4294919581 @default.
• W4313590933 cites W4298325681 @default.
• W4313590933 cites W4306398823 @default.
• W4313590933 doi "https://doi.org/10.3390/molecules28010077" @default.
• W4313590933 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36615273" @default.
• W4313590933 hasPublicationYear "2022" @default.
• W4313590933 type Work @default.
• W4313590933 citedByCount "0" @default.
• W4313590933 crossrefType "journal-article" @default.
• W4313590933 hasAuthorship W4313590933A5014836794 @default.
• W4313590933 hasAuthorship W4313590933A5023372956 @default.
• W4313590933 hasAuthorship W4313590933A5036554864 @default.
• W4313590933 hasAuthorship W4313590933A5040352588 @default.

• next